Does constipation at week eight of orforglipron usually resolve without a dose change?

For reference: constipation · eight · orforglipron.

I have done this once and I suspect I got away with it rather than got it right.

For context: I keep records of every batch, every lot number and every result, so an answer that requires me to track something is fine.

What would you do, and what would you check afterwards?

Week 8 is day 56: on a four-week ladder that is week 4 of dose step 2, and — at the seven-day half-life this class runs on — 8 half-lives in. Steady state is about five half-lives, so day 35 is where the concentration stops climbing on its own. Day 56 is 3 weeks past it, which means the level is no longer the variable. That distinction is most of the question: at week 4 of a step, an effect that is still accumulating is indistinguishable from one that is not resolving unless you know which side of day 35 you are on. Constipation is the one that does not follow the escalation curve. It builds with cumulative exposure and with the fall in food and fluid volume, so it characteristically appears later than nausea and outlasts it by months. Dose decisions are made under supervision, and nothing here is medical advice.

Answering this needs the actual fibre and fluid intake, and people are almost always taking less of both than they think.

Physical activity has a modest but real effect on transit time and is free, which makes it worth including even though it will not fix this on its own.

Gastrointestinal adverse events, indicative pooled rates

Ranges span agents and doses; read the specific prescribing information for a specific figure.

The underlying point is that osmotic agents such as macrogol draw water into the lumen and are the usual first pharmacological step; they work with the mechanism rather than against it.

Nothing here is medical advice.

Pain, distension and vomiting together are urgent. That is not constipation.

Answer first: constipation here is predominantly a reduced-intake problem — less food, less fibre, less fluid — before it is a motility problem.

Red flags that change this from a management question to a clinical one: no bowel movement for several days with abdominal distension and vomiting, blood in the stool, or unexplained weight loss beyond what is expected.

Aim for 25 to 30 grams of fibre a day, which requires deliberate planning at a reduced total intake because fibre-rich foods are bulky and satiating exactly when appetite is suppressed.

Long-term stimulant laxative use is a clinical decision rather than a self-management default.

Fibre and fluid together. Fibre alone makes it worse and that is the commonest mistake.

Severe abdominal pain with no bowel movement and vomiting is a different problem entirely and is urgent.

Soluble fibre — psyllium, oats, legumes — holds water and softens stool. Insoluble fibre adds bulk and speeds transit. In slowed-transit constipation the soluble kind is generally the more useful of the two.

Adding fibre without adding fluid produces a larger, drier, harder stool and makes the problem worse. The fluid is not optional and is the step people skip.

This one does not attenuate with tolerance. Plan for it rather than waiting it out.

edited 22 Jan 2026 by Dr_Otto_Lindqvist — updated for the 2026 guidance change

Worth being precise here: this is the adverse effect that persists longest, because unlike nausea it does not attenuate with tolerance.

Magnesium-containing preparations act osmotically and are widely used; they are a laxative rather than a supplement in this context, and the dose is what makes the difference.

Osmotic first, stimulant reluctantly, and not as a standing arrangement.